A major breakthrough has been announced by Sidra Medicine — and it could change the future of treating serious blood diseases! 🧬✨ The hospital is introducing an advanced gene-editing therapy using CRISPR technology, designed as a one-time treatment that targets the root cause of disease instead of just managing symptoms.
But what does it actually treat? 🤔
It is aimed at patients with sickle cell disease and beta thalassemia. In sickle cell disease, red blood cells become stiff and sickle-shaped, blocking blood flow and causing severe pain. In beta thalassemia, the body cannot produce enough healthy hemoglobin, leading to constant anemia and repeated blood transfusions.
So how does this new therapy work? 🧪
Doctors take the patient’s stem cells, correct the faulty gene in a lab, and return the repaired cells to the body. Once they start working, the bone marrow can produce healthier red blood cells. Imagine that — fixing the problem at its source! 😮
Could this mean fewer hospital visits? Could it reduce lifelong transfusions? 💉➡️❌ Many patients may experience major improvements, even long-term relief!
Of course, there are risks. The process includes chemotherapy and is still being studied for long-term effects. But still… isn’t it incredible that medicine is moving from “treating” to “fixing”? 🚀
No comments:
Post a Comment